230 related articles for article (PubMed ID: 27029823)
21. Clinical evaluation of P-glycoprotein inhibition by venetoclax: a drug interaction study with digoxin.
Chiney MS; Menon RM; Bueno OF; Tong B; Salem AH
Xenobiotica; 2018 Sep; 48(9):904-910. PubMed ID: 29027832
[TBL] [Abstract][Full Text] [Related]
22. The effects of a high-fat meal on single-dose vemurafenib pharmacokinetics.
Ribas A; Zhang W; Chang I; Shirai K; Ernstoff MS; Daud A; Cowey CL; Daniels G; Seja E; O'Laco E; Glaspy JA; Chmielowski B; Hill T; Joe AK; Grippo JF
J Clin Pharmacol; 2014 Apr; 54(4):368-74. PubMed ID: 24374975
[TBL] [Abstract][Full Text] [Related]
23. Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: a single-dose, randomized, open-label, crossover study in healthy subjects.
Henney HR; Shah J
Clin Ther; 2007 Apr; 29(4):661-9. PubMed ID: 17617289
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the effects of formulation and food on the pharmacokinetics of lenvatinib (E7080) in healthy volunteers.
Shumaker R; Aluri J; Fan J; Martinez G; Ren M; Chen K
Int J Clin Pharmacol Ther; 2014 Apr; 52(4):284-91. PubMed ID: 24548978
[TBL] [Abstract][Full Text] [Related]
25. Dose proportionality and the effects of food on bioavailability of an immediate-release oxycodone hydrochloride tablet designed to discourage tampering and its relative bioavailability compared with a marketed oxycodone tablet under fed conditions: a single-dose, randomized, open-label, 5-way crossover study in healthy volunteers.
Bass A; Stark JG; Pixton GC; Sommerville KW; Zamora CA; Leibowitz M; Rolleri R
Clin Ther; 2012 Jul; 34(7):1601-12. PubMed ID: 22717418
[TBL] [Abstract][Full Text] [Related]
26. Effects of food on the pharmacokinetics of ponatinib in healthy subjects.
Narasimhan NI; Dorer DJ; Niland K; Haluska F; Sonnichsen D
J Clin Pharm Ther; 2013 Dec; 38(6):440-4. PubMed ID: 23888935
[TBL] [Abstract][Full Text] [Related]
27. Venetoclax does not prolong the QT interval in patients with hematological malignancies: an exposure-response analysis.
Freise KJ; Dunbar M; Jones AK; Hoffman D; Enschede SL; Wong S; Salem AH
Cancer Chemother Pharmacol; 2016 Oct; 78(4):847-53. PubMed ID: 27586967
[TBL] [Abstract][Full Text] [Related]
28. Effect of Azithromycin on Venetoclax Pharmacokinetics in Healthy Volunteers: Implications for Dosing Venetoclax with P-gp Inhibitors.
Agarwal SK; Tong B; Bueno OF; Menon RM; Salem AH
Adv Ther; 2018 Nov; 35(11):2015-2023. PubMed ID: 30264382
[TBL] [Abstract][Full Text] [Related]
29. A randomized, phase I, 3-way crossover study to examine the effects of food on the pharmacokinetics of single doses of 400 mg posaconazole oral suspension in healthy male Taiwanese subjects.
Lin TY; Yang MH; Chang FY
Ther Drug Monit; 2013 Apr; 35(2):223-7. PubMed ID: 23503449
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of food effect on the oral bioavailability of pradigastat, a diacylglycerol acyltransferase 1 inhibitor.
Ayalasomayajula SP; Meyers CD; Yu J; Kagan M; Matott R; Pal P; Majumdar T; Su Z; Crissey A; Rebello S; Sunkara G; Chen J
Biopharm Drug Dispos; 2015 Oct; 36(7):452-61. PubMed ID: 25963481
[TBL] [Abstract][Full Text] [Related]
31. Clinical development of an everolimus pediatric formulation: relative bioavailability, food effect, and steady-state pharmacokinetics.
Kovarik JM; Noe A; Berthier S; McMahon L; Langholff WK; Marion AS; Hoyer PF; Ettenger R; Rordorf C
J Clin Pharmacol; 2003 Feb; 43(2):141-7. PubMed ID: 12616666
[TBL] [Abstract][Full Text] [Related]
32. Effect of a high-fat meal on the bioavailability of a polymer-coated erythromycin particle tablet formulation.
Randinitis EJ; Sedman AJ; Welling PG; Kinkel AW
J Clin Pharmacol; 1989 Jan; 29(1):79-84. PubMed ID: 2708552
[TBL] [Abstract][Full Text] [Related]
33. Impact of food and different meal types on the pharmacokinetics of rilpivirine.
Crauwels HM; van Heeswijk RP; Buelens A; Stevens M; Boven K; Hoetelmans RM
J Clin Pharmacol; 2013 Aug; 53(8):834-40. PubMed ID: 23720136
[TBL] [Abstract][Full Text] [Related]
34. Effects of food and antacids on the pharmacokinetics of eltrombopag in healthy adult subjects: two single-dose, open-label, randomized-sequence, crossover studies.
Williams DD; Peng B; Bailey CK; Wire MB; Deng Y; Park JW; Collins DA; Kapsi SG; Jenkins JM
Clin Ther; 2009 Apr; 31(4):764-76. PubMed ID: 19446149
[TBL] [Abstract][Full Text] [Related]
35. Effect of food and tablet-dissolution characteristics on the bioavailability of linagliptin fixed-dose combination with metformin: evidence from two randomized trials.
Metzmann K; Schnell D; Jungnik A; Ring A; Theodor R; Hohl K; Meinicke T; Friedrich C
Int J Clin Pharmacol Ther; 2014 Jul; 52(7):549-63. PubMed ID: 24755124
[TBL] [Abstract][Full Text] [Related]
36. Effects of food intake on the pharmacokinetic properties of mirabegron oral controlled-absorption system: a single-dose, randomized, crossover study in healthy adults.
Lee J; Zhang W; Moy S; Kowalski D; Kerbusch V; van Gelderen M; Sawamoto T; Grunenberg N; Keirns J
Clin Ther; 2013 Mar; 35(3):333-41. PubMed ID: 23497763
[TBL] [Abstract][Full Text] [Related]
37. Effects of food intake on the pharmacokinetic properties of dalcetrapib: findings from three phase I, single-dose crossover studies in healthy volunteers.
Derks M; Kawamura H; Abt M; Meneses-Lorente G; Phelan M; Ishikawa T
Clin Ther; 2011 Jun; 33(6):754-65. PubMed ID: 21704240
[TBL] [Abstract][Full Text] [Related]
38. The pharmacokinetics of cinacalcet are unaffected following consumption of high- and low-fat meals.
Padhi D; Salfi M; Harris RZ
Am J Ther; 2007; 14(3):235-40. PubMed ID: 17515696
[TBL] [Abstract][Full Text] [Related]
39. Bioavailability of a controlled-release cyclobenzaprine tablet and influence of a high fat meal on bioavailability.
Gai MN; Costa E; Arancibia A
Int J Clin Pharmacol Ther; 2009 Apr; 47(4):269-74. PubMed ID: 19356393
[TBL] [Abstract][Full Text] [Related]
40. Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma.
Davids MS; Roberts AW; Seymour JF; Pagel JM; Kahl BS; Wierda WG; Puvvada S; Kipps TJ; Anderson MA; Salem AH; Dunbar M; Zhu M; Peale F; Ross JA; Gressick L; Desai M; Kim SY; Verdugo M; Humerickhouse RA; Gordon GB; Gerecitano JF
J Clin Oncol; 2017 Mar; 35(8):826-833. PubMed ID: 28095146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
